Dr. Jane M. Love, co-vice chair of the firm's Intellectual Property Department, is a patent attorney with a practice focused on life sciences issues in the areas of patent litigation, patent prosecution, patent interferences, reexaminations, and strategic patent portfolio advice and diligence. Dr. Love has deep experience in biotechnology and chemistry patent issues. Dr. Love’s practice encompasses ANDA litigation, biologics litigation, advice related to biosimilars, post-grant proceedings under the AIA and global coordination of prosecution and enforcement of patent rights.
Patent Advice: Dr. Love advises her clients on how to create and shape an intellectual property portfolio to protect valuable ideas and discoveries. Dr. Love prepares and prosecutes patent applications and manages large portfolios of patents in the US and globally. Dr. Love serves clients in the life sciences areas, especially in the fields of biotechnology, molecular biology, biology, biochemistry, immunology, nanotechnology and chemistry. Dr. Love has been entrusted with obtaining IP protection on significant innovations such as gene and protein therapeutics, molecular diagnostics, vaccines, treatment methods, pharmaceutical compounds, and formulations. Dr. Love is experienced in providing strategic patent advice to large and small companies, biotech and pharmaceutical start-up companies, universities and research institutions.
IP Litigation: Dr. Love utilizes the experience she has in core IP areas to represent clients in IP litigation related to life sciences patents. In particular, Dr. Love has litigation experience in the areas of antibody technology, Hatch-Waxman litigation related to pharmaceutical molecules, and synthetic peptide therapeutics.
IP Advice in Transactions: Dr. Love provides advice to large and small companies, as well as to potential investors, with regard to intellectual property that may form the basis of value in technology-related transactions. Dr. Love has experience in IP due diligence, invalidity and non-infringement opinions, patentability assessments, freedom-to-operate analyses, competitive landscape analyses and overall patent strategy.
Patent Interferences: Dr. Love is one of the few patent practitioners with significant experience in the difficult area of patent interference practice before the Board of Patent Appeals and Interferences. In addition, her practice includes representation in other contentious proceedings such as reexaminations at the USPTO, and advice as co-counsel with European agents in Opposition proceedings.
Dr. Love was a panelist at the April 2011 19th Annual Conference Intellectual Property Law & Policy for Fordham Intellectual Property Law Institute in New York, speaking about the Myriad case and gene patents. In January 2010, she spoke for the IP Due Diligence Conference in New York on biotech and pharma transactions by the American Conference Institute. In May 2009, she spoke at the Emerging Growth Markets Conference by Sanford C. Bernstein & Co., LLC in New York City about "Legal Perspectives in the Acquisition of Intellectual Property Rights in Emerging Markets." In June 2008, she was a panelist at "Pathways To Leadership: Keys to Success For Women In The Law," an event held by the New York City Bar Association. In October 2004, Dr. Love spoke about "Extracting Value from Intellectual Property" for the Silicon Alley Entrepreneur's Club (SAEC).